TLR9-based immunotherapy for allergic disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Medicine

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJMED.2005.12.028PMID 17000223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-priming: a novel approach to DNA-based vaccination and immunomodulation

  2009cited by this paper
• Introduction to immunostimulatory DNA sequences

  2009cited by this paper
• The natural history of allergy: the development of new sensitizations in asthmatic children.

  2004cited by this paper
• Drug development strategies for asthma: in search of a new paradigm

  2004cited by this paper
• Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.

  2004cited by this paper
• New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA.

  2004cited by this paper
• Allergen‐independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis

  2004cited by this paper
• Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.

  2004cited by this paper
• Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling.

  2004cited by this paper
• Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.

  2004cited by this paper
• Antigen–immunostimulatory oligonucleotide conjugates: mechanisms and applications

  2004cited by this paper
• Immunostimulatory DNA Reverses Established Allergen-Induced Airway Remodeling1

  2004cited by this paper
• Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys.

  2004cited by this paper
• Modulation of Airway Inflammation by Immunostimulatory CpG Oligodeoxynucleotides in a Murine Model of Allergic Aspergillosis

  2004cited by this paper
• Toward asthma prevention--does all that really matters happen before we learn to read?

  2003cited by this paper
• Toll-like receptors.

  2003cited by this paper
• A longitudinal, population-based, cohort study of childhood asthma followed to adulthood.

  2003cited by this paper
• Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids.

  2003cited by this paper
• Tucson Children's Respiratory Study: 1980 to present.

  2003cited by this paper
• Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure.

  2003cited by this paper
• Progress in the development of new methods of immunotherapy: potential application of immunostimulatory DNA-conjugated to allergens for treatment of allergic respiratory conditions.

  2003cited by this paper
• CpG motifs in bacterial DNA and their immune effects.

  2002cited by this paper
• Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.

  2002cited by this paper
• Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases.

  2002cited by this paper
• CTLA-4–Ig regulates tryptophan catabolism in vivo

  2002cited by this paper
• Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis.

  2002cited by this paper
• Balancing safety and efficacy in the treatment of pediatric asthma.

  2002cited by this paper
• Extinguishing maternal immune responses during pregnancy: implications for immunosuppression.

  2001cited by this paper
• Novel Roles of CpG Oligodeoxynucleotides as a Leader for the Sampling and Presentation of CpG-Tagged Antigen by Dendritic Cells1

  2001cited by this paper
• The germless theory of allergic disease: revisiting the hygiene hypothesis

  2001cited by this paper
• Immunostimulatory DNA-Based Vaccines Elicit Multifaceted Immune Responses Against HIV at Systemic and Mucosal Sites1

  2001cited by this paper
• The consideration of immunotherapy in the treatment of allergic asthma.

  2001cited by this paper
• Systemic Administration of Immunostimulatory DNA Sequences Mediates Reversible Inhibition of Th2 Responses in a Mouse Model of Asthma

  2001cited by this paper
• Enhancement of Innate Immunity againstMycobacterium avium Infection by Immunostimulatory DNA Is Mediated by Indoleamine 2,3-Dioxygenase

  2001cited by this paper
• Immunostimulatory DNA inhibits IL-4-dependent IgE synthesis by human B cells.

  2001cited by this paper
• Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant.

  2000cited by this paper
• The consideration of immunotherapy in the treatment of allergic asthma.

  2000cited by this paper
• DNA-based vaccination reduces the risk of lethal anaphylactic hypersensitivity in mice.

  2000cited by this paper
• Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitis

  2000cited by this paper
• CpG Oligodeoxynucleotides Can Reverse Th2-Associated Allergic Airway Responses and Alter the B7.1/B7.2 Expression in a Murine Model of Asthma1

  2000cited by this paper
• Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.

  2000cited by this paper
• Conjugation of protein to immunostimulatory DNA results in a rapid, long‐lasting and potent induction of cell‐mediated and humoral immunity

  2000cited by this paper
• Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity.

  2000cited by this paper
• Airway remodeling in asthma.

  1999cited by this paper
• Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides.

  1999cited by this paper
• Enhancement of antigen-presenting cell surface molecules involved in cognate interactions by immunostimulatory DNA sequences.

  1999cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

  1998cited by this paper
• Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice.

  1998cited by this paper
• Cutting Edge: Modulation of Airway Inflammation by CpG Oligodeoxynucleotides in a Murine Model of Asthma

  1998cited by this paper
• Is allergy increasing? – early life influences

  1998cited by this paper
• Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.

  1998cited by this paper
• Allergen immunotherapy: therapeutic vaccines for allergic diseases

  1998cited by this paper
• A novel murine model of allergic conjunctivitis.

  1998cited by this paper
• Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract.

  1997cited by this paper
• Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

  1997cited by this paper
• CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

  1996cited by this paper
• Sorting out the cytokines of asthma

  1996cited by this paper
• An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.

  1996cited by this paper
• Ragweed immunotherapy in adult asthma.

  1996cited by this paper
• Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.

  1995cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Synthetic Oligonucleotides with Certain Palindromes Stimulate Interferon Production of Human Peripheral Blood Lymphocytes in vitro

  1994cited by this paper
• Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

  1992cited by this paper
• Synthetic Oligonucleotides with Particular Base Sequences from the cDNA Encoding Proteins of Mycobacterium bovis BCG Induce Interferons and Activate Natural Killer Cells

  1992cited by this paper
• Interferon-Induced Indoleamine 2,3-Dioxygenase Activity Inhibits Chlamydia psittaci Replication in Human Macrophages

  1989cited by this paper
• In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCG

  1988cited by this paper
• Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.

  1984cited by this paper

• cGAS-STING signaling in cardiovascular diseases

  2024cites this paper
• Mechanism of PM2.5 Induced/Aggravated Allergic Diseases and its Prevention and Treatment

  2024cites this paper
• Pneumococcal Δpep27 Immunization Attenuates TLRs and NLRP3 Expression and Relieves Murine Ovalbumin-Induced Allergic Rhinitis

  2022cites this paper
• Recent advances in improving intranasal allergen-specific immunotherapy; focus on delivery systems and adjuvants.

  2022cites this paper
• Ameliorating effect of CpG-ODN (oligodeoxynucleotide) against radiation-induced lung injury in mice

  2020cites this paper
• Toll-like receptor-9 (TLR-9) deficiency alleviates optic nerve injury (ONI) by inhibiting inflammatory response in vivo and in vitro.

  2020cites this paper
• Revisiting the interaction of heme with hemopexin: Recommendations for the responsible use of an emerging drug

  2020cites this paper
• CpG-ODN Shapes Alum Adjuvant Activity Signaling via MyD88 and IL-10

  2017cites this paper
• TLR9-based immunotherapy for the treatment of allergic diseases.

  2017cites this paper
• Adjuvanzien

  2017cites this paper
• The epithelial barrier and immunoglobulin A system in allergy

  2016cites this paper
• Interaction Between Helminths and Toll-Like Receptors: Possibilities and Potentials for Asthma Therapy

  2016cites this paper
• TLR9 expression is required for the development of cigarette smoke-induced emphysema in mice.

  2016cites this paper
• Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production

  2016cites this paper
• Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice

  2015cites this paper
• Animal Models in Biomedical Research

  2015cites this paper
• Negative health implications of sickle cell trait in high income countries: from the football field to the laboratory

  2015cites this paper
• IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII.

  2015cites this paper
• Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options

  2015cites this paper
• Formulation, characterization and validation of CpG functionalized PLGA bacteriomimetic nanoparticles for breast cancer immunotherapy

  2015cites this paper
• Increased Expression of Toll-Like Receptors 2 and 4 and Related Cytokines in Persistent Allergic Rhinitis

  2015cites this paper
• Hyponatremia and hypokalemia as risk factors for falls

  2014cites this paper
• The spleen and sickle cell disease: the sick(led) spleen

  2014cites this paper
• The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: a prospective study of 0-3 years-old children in Turkey.

  2014cites this paper
• Targeting Toll-like receptor signaling as a novel approach to prevent ocular infectious diseases

  2013cites this paper
• Hemostatic Aspects of Sickle Cell Disease

  2013cites this paper
• Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease

  2012cites this paper
• Role of innate immunity in the pathogenesis of allergic rhinitis

  2012cites this paper
• Preexposure to CpG Protects against the Delayed Effects of Neonatal Respiratory Syncytial Virus Infection

  2012cites this paper
• Cockroach Allergen per a 7 Down-Regulates Expression of Toll-Like Receptor 9 and IL-12 Release from P815 Cells Through PI3K and MAPK Signaling Pathways

  2012cites this paper
• TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis

  2012cites this paper
• Dual Role of Toll-Like Receptors in Asthma and Chronic Obstructive Pulmonary Disease

  2012cites this paper
• Pulmonary embolism in sickle cell disease: a case–control study

  2012cites this paper
• Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia

  2012cites this paper
• The active contribution of Toll-like receptors to allergic airway inflammation.

  2011cites this paper
• Bronchial hyperresponsiveness and lung inflammation induced by allergic immune response and oxidative stress: role of innate and adaptive immune responses

  2011cites this paper
• How I treat acute chest syndrome in children with sickle cell disease.

  2011cites this paper
• Acute chest syndrome: sickle cell disease

  2011cites this paper
• Toll-like receptors in ocular surface disease.

  2010cites this paper
• Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis

  2010cites this paper
• Toll-like receptor expression and function at the ocular surface

  2010cites this paper
• Thrombosis in the pediatric population.

  2010cites this paper
• Monoclonal antibodies and other biologic agents in the treatment of asthma

  2009cites this paper
• Role of atopic status in Toll‐like receptor (TLR)7‐ and TLR9‐mediated activation of human eosinophils

  2009cites this paper
• Characterisation of the gut mucosa-adherent microbiota : environmental influences contributions to immune development

  2009cites this paper
• Cord serum immunoglobulin E as a risk factor for allergic symptoms and sensitization in children and young adults

  2009cites this paper
• Molecular Biology of Allergens: Structure and Immune Recognition

  2009cites this paper
• Immunomodulators in asthma therapy

  2009cites this paper
• Nerve growth factor modulates toll-like receptor (TLR) 4 and 9 expression in cultured primary VKC conjunctival epithelial cells

  2009cites this paper
• Immunomodulators in the treatment of asthma.

  2009cites this paper
• Immune modulatory oligonucleotides in the prevention and treatment of allergen-induced eustachian tube dysfunction in the animal model

  2008cites this paper
• Early life determinants of atopy : A 20-year prospective follow-up study on unselected, healthy newborns

  2008cites this paper
• [Systemic lupus erythematosus: news and therapeutic perspectives].

  2008cites this paper
• The effect of toll-like receptors and toll-like receptor genetics in human disease.

  2008cites this paper
• Toll-like receptors in the respiratory system: Their roles in inflammation

  2008influential citation
• Immunomodulators for allergic respiratory disorders.

  2008cites this paper
• Actualités et perspectives thérapeutiques du lupus systémique

  2008cites this paper
• Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.

  2008cites this paper
• Putative association of a TLR9 promoter polymorphism with atopic eczema

  2007cites this paper
• Targeting toll‐like receptors for drug development: a summary of commercial approaches

  2007cites this paper
• TLR9-Based Immunotherapy for Allergic Disease

  2007cites this paper
• Novel immunomodulatory oligonucleotides for cancer therapy

  2007cites this paper
• Impact of asthma, environmental exposures and ethnicity on functional responsiveness to Toll-like receptor (TLR) stimulation in children

  2007cites this paper
• IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation

  2007cites this paper
• CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy

  2007cites this paper
• Immunostimulatory sequences in immunotherapy

  2007cites this paper
• At long last: clinically significant immunomodulatory therapies

  2007cites this paper
• Molecular cloning and characterization of equine Toll-like receptor 9.

  2007cites this paper